Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial

Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2024-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10796039/?tool=EBI

Similar Items

Retraction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
by: PLOS ONE Editors
Published: (2024-01-01)

2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
by: Msolli Mohamed Amine, et al.
Published: (2021-01-01)

Correction: 2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
by: PLOS ONE Staff
Published: (2021-01-01)

Two-day seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial
by: Salma Messous, et al.
Published: (2022-06-01)

Expression of concern: ‘Two-day versus seven-day course of levofloxacin in acute COPD exacerbation: a randomized controlled trial’
Published: (2023-08-01)

Efficacy of levofloxacin versus cefuroxime in treating acute exacerbations of chronic obstructive pulmonary disease
by: Yoon HI, et al.
Published: (2013-07-01)

C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations
by: Butler, C, et al.
Published: (2019)

Prophylactic antibiotherapy in Neurosurgery
by: G. Iacob, et al.
Published: (2010-09-01)

Acute exacerbations of COPD
by: W MaxNee
Published: (2003-05-01)

Microbial Resistance to Antibiotics and Effective Antibiotherapy
by: Adriana Aurelia Chiș, et al.
Published: (2022-05-01)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial.
by: Siva, R, et al.
Published: (2014)

Effect of levofloxacin on neutrophilic airway inflammation in stable COPD: a randomized, double-blind, placebo-controlled trial
by: Siva R, et al.
Published: (2014-02-01)

C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity
by: Gallego M, et al.
Published: (2016-10-01)

Antibiotherapy in Children with Cystic Fibrosis—An Extensive Review
by: Ioana Mihaiela Ciuca, et al.
Published: (2022-08-01)

THE LOCAL ANTIBIOTHERAPY IN THE PERIODONTAL DISEASE TREATMENT. REVIEW
by: Sorina-Mihaela Solomon, et al.
Published: (2019-07-01)

Efficacy of antibiotherapy for treating flatus incontinence associated with small intestinal bacterial overgrowth: A pilot randomized trial.
by: Chloé Melchior, et al.
Published: (2017-01-01)

Effects of Chinese medicine on patients with acute exacerbations of COPD: study protocol for a randomized controlled trial
by: Hailong Zhang, et al.
Published: (2019-12-01)

High-flow nasal cannula versus conventional oxygen therapy in acute COPD exacerbation with mild hypercapnia: a multicenter randomized controlled trial
by: Jingen Xia, et al.
Published: (2022-04-01)

Acute exacerbations of COPD versus IPF in patients with combined pulmonary fibrosis and emphysema
by: Massa Zantah, et al.
Published: (2020-06-01)

Antibiotic prevention of acute exacerbations of COPD.
by: Chapman, S
Published: (2012)

Noninvasive ventilation in acute exacerbations of COPD
by: M. W. Elliott
Published: (2005-09-01)

Determining prognosis in acute exacerbation of COPD
by: Flattet Y, et al.
Published: (2017-01-01)

The radiological manifestations of acute exacerbations of COPD
by: C. Feldman, et al.
Published: (2014-04-01)

Impact of antibiotics on acute exacerbations of COPD
by: Wafaa Ali Hassan, et al.
Published: (2015-07-01)

Clinical Features and C-Reactive Protein as Predictors of Bacterial Exacerbations of COPD
by: Francis NA, et al.
Published: (2020-12-01)

Day-to-Day Variability of Parameters Recorded by Home Noninvasive Positive Pressure Ventilation for Detection of Severe Acute Exacerbations in COPD
by: Jiang W, et al.
Published: (2021-03-01)

Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review
by: Marion Dubald, et al.
Published: (2018-01-01)

THE ROLE OF ANTIBIOTHERAPY IN THE ORAL REHABILITATION OF THE PERIODONTAL AFFECTED PATIENT
by: Mihaela Moisei, et al.
Published: (2015-04-01)

Levofloxacin versus clarithromycin for Helicobacter pylori eradication: are 14 day regimens better than 10 day regimens?
by: Eman T. Azab, et al.
Published: (2022-06-01)

Long- versus short-duration systemic corticosteroid regimens for acute exacerbations of COPD: A systematic review and meta-analysis of randomized trials and cohort studies
by: Zhen Zhao, et al.
Published: (2023-01-01)

Effect of Panax Ginseng (G115) Capsules versus Placebo on Acute Exacerbations in Patients with Moderate to Very Severe COPD: A Randomized Controlled Trial
by: Chen Y, et al.
Published: (2020-03-01)

Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial
by: Sandau C, et al.
Published: (2023-04-01)

Methylprednisolone vs Dexamethasone in Management of COPD Exacerbation; a Randomized Clinical Trial
by: Mohammad Emami Ardestani, et al.
Published: (2016-12-01)

Methylprednisolone vs Dexamethasone in Management of COPD Exacerbation; a Randomized Clinical Trial
by: Mohammad Emami Ardestani, et al.
Published: (2018-12-01)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
by: Eriksson G, et al.
Published: (2017-05-01)

Readmission After COPD Exacerbation Scale: determining 30-day readmission risk for COPD patients
by: Lau CSM, et al.
Published: (2017-06-01)

Comparison of Levofloxacin-Based, 10-day Sequential Therapy with 14-day Quadruple Therapy for Helicobacter Pylori Eradication: A Randomized Clinical Trial
by: Eskandar Hajiani, et al.
Published: (2018-10-01)

Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study
by: Davood Yadegarynia, et al.
Published: (2022-08-01)

Cefditoren versus levofloxacin in patients with exacerbations of chronic bronchitis: serum inflammatory biomarkers, clinical efficacy, and microbiological eradication
by: Blasi F, et al.
Published: (2013-02-01)

Role of C-reactive protein and interleukin-6 in predicting the prognosis of ICU-admitted patients with acute exacerbation of COPD
by: Tamer Abdullah Helmy, et al.
Published: (2014-10-01)